Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.
Also called NCT07115953
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT07115953
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Belgium, Germany, Greece, Ireland, Malaysia, Netherlands, Taiwan, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT07115953. Allocation not applicable; no masking; primary purpose treatment. Start 2025-09-22 (actual); primary completion 2027-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
- Acronym
- SWYFT
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Chronic Kidney Diseases
- Condition
- Diabetes Mellitus
- Intervention (Device)
- Symplicity Spyral™ multi-electrode renal denervation system
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct07115953- Content hash
6f015a1e5e03b051b06050d4933c71732ab7ecf40587e7df9e67b93886157529